Literature DB >> 29313068

Advantage of landiolol over esmolol? We doubt it!

Guenther Frank1, Robert Denham Fitzgerald2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29313068     DOI： 10.1007/s00228-017-2408-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts.

Authors:  Shigehiro Shibata; Yosuke Okamoto; Shigeatsu Endo; Kyoichi Ono
Journal:  J Pharmacol Sci       Date:  2012-02-01       Impact factor: 3.337

2.  Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.

Authors:  Günther Krumpl; Ivan Ulc; Michaela Trebs; Pavla Kadlecová; Juri Hodisch
Journal:  Eur J Clin Pharmacol       Date:  2017-01-13       Impact factor: 2.953

3.  Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.

Authors:  Shahrooz Nasrollahi-Shirazi; Sonja Sucic; Qiong Yang; Michael Freissmuth; Christian Nanoff
Journal:  J Pharmacol Exp Ther       Date:  2016-07-22       Impact factor: 4.030
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.